Atara Biotherapeutics, Inc.

Introduction

This page provides a comprehensive analysis of the known insider trading history of Clark Mitchall G.. Insiders are officers, directors, or significant investors in a company. It is illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4. Despite these restrictions, academic research suggests that insiders - in general - tend to outperform the market in their own companies.

Average Trade Profitability

The average trade profitability is the average return of all the open market purchases made by the insider in the last three years. To calculate this, we examine every open-market, unplanned purchase made by the insider, excluding all trades that were marked as part of a 10b5-1 trading plan. We then calculate the average performance of those trades over 3, 6, and 12 months, averaging each of those durations to generate a final performance metric for each trade. Finally, we average all of the performance metrics to calculate a performance metric for the insider. This list only includes insiders that have made at least three trades in the last two years.

If this insiders trade profitability is "N/A", then the insider either has not made any open-market purchases in the last three years, or the trades they’ve made are too recent to calculate a reliable performance metric.

Update Frequency: Daily

See the list of most profitable insider traders.

Companies with Reported Insider Positions

The SEC filings indicate Clark Mitchall G. has reported holdings or trades in the following companies:

Security Title Latest Reported Holdings
US:ATRA / Atara Biotherapeutics, Inc. EVP & Chief R & QA Officer 107,972
How to Interpret the Charts

The following charts show the stock performance of securities subsequent to each open-market, non-planned trade made by Clark Mitchall G.. Non-planned trade are trades that were not made as part of a 10b5-1 trading plan. The stock performance is charted as cumulative percent change in share price. For example, if an insider trade was made on January 1, 2019, the chart will show the daily percent change of the security to the present day. If the share price were to go from $10 to $15 during this time, the cumulative percent change in share price would be 50%. A change in price from $10 to $20 would be 100%, and a change in price of $10 to $5 would be -50%.

Ultimately, we are trying to determine how closely the insider’s trades correlate to excess returns (positive or negative) in the share price in order to see if the insider is timing their trades to profit from insider information. Consider the situation where an insider was doing this. In this situation, we would expect either (a) positive returns after purchases, or (b) negative returns after sales. In the case of (a), the PURCHASE chart would show a series of upwardly sloping curves, indicating positive returns after each purchase transaction. In the case of (b), the SALE chart would show a series of downward sloping curves, indicating negative returns after each sale transaction.

However, this alone is not enough to draw conclusions. If, for example, the share price of the company was in a non-cyclical climb over many years, then we would expect all the post-purchase plots to be upwardly sloping. Likewise, non-cyclical declines over many years would result in downward sloping post-trade plots. Neither of these charts would suggest insider trading activity.

The strongest indicator would be a situation where the share price was extremely cyclical, and there were both positive signals in the PURCHASE chart and negative plots on the SALE chart. This situation would be highly suggestive of an insider that was timing trades to their financial advantage.

Insider Purchases ATRA / Atara Biotherapeutics, Inc. - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in ATRA / Atara Biotherapeutics, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

ATRA / Atara Biotherapeutics, Inc. Insider Trades
Insider Sales ATRA / Atara Biotherapeutics, Inc. - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in ATRA / Atara Biotherapeutics, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

ATRA / Atara Biotherapeutics, Inc. Insider Trades
Insider Trading History

This table shows the complete list of insider trades made by Clark Mitchall G. as disclosed to the Securities Exchange Commission (SEC).

File Date Tran Date Form Ticker Security Code 10b5-1 Shares Remaining Shares Percent
Change
Share
Price
Tran
Value
Remaining
Value
2018-05-21 2018-05-18 4 ATRA Atara Biotherapeutics, Inc.
Common Stock
S - Sale X -25,860 107,972 -19.32 50.03 -1,293,776 5,401,839
2018-05-16 2018-05-16 4 ATRA Atara Biotherapeutics, Inc.
Common Stock
S - Sale X -300 133,832 -0.22 46.30 -13,890 6,196,422
2018-05-16 2018-05-16 4 ATRA Atara Biotherapeutics, Inc.
Common Stock
S - Sale X -4,347 134,132 -3.14 46.04 -200,136 6,175,437
2018-05-16 2018-05-15 4 ATRA Atara Biotherapeutics, Inc.
Restricted Stock Units
M - Exercise -4,808 0 -100.00
2018-05-16 2018-05-15 4 ATRA Atara Biotherapeutics, Inc.
Common Stock
M - Exercise 4,808 138,479 3.60
2018-04-03 2018-03-29 4 ATRA Atara Biotherapeutics, Inc.
Common Stock
S - Sale X -22,400 133,671 -14.35 40.07 -897,568 5,356,197
2018-03-28 2018-03-27 4 ATRA Atara Biotherapeutics, Inc.
Employee Stock Option (Right to Buy)
M - Exercise X -11,406 3,125 -78.49
2018-03-28 2018-03-27 4 ATRA Atara Biotherapeutics, Inc.
Employee Stock Option (Right to Buy)
M - Exercise X -32,500 32,500 -50.00
2018-03-28 2018-03-27 4 ATRA Atara Biotherapeutics, Inc.
Employee Stock Option (Right to Buy)
M - Exercise X -28,848 11,194 -72.04
2018-03-28 2018-03-27 4 ATRA Atara Biotherapeutics, Inc.
Common Stock
S - Sale X -11,103 156,071 -6.64 41.10 -456,333 6,414,518
2018-03-28 2018-03-27 4 ATRA Atara Biotherapeutics, Inc.
Common Stock
S - Sale X -2,800 167,174 -1.65 40.40 -113,120 6,753,830
2018-03-28 2018-03-27 4 ATRA Atara Biotherapeutics, Inc.
Common Stock
S - Sale X -2,170 169,974 -1.26 39.53 -85,780 6,719,072
2018-03-28 2018-03-27 4 ATRA Atara Biotherapeutics, Inc.
Common Stock
S - Sale X -29,980 172,144 -14.83 38.23 -1,146,135 6,581,065
2018-03-28 2018-03-27 4 ATRA Atara Biotherapeutics, Inc.
Common Stock
S - Sale X -31,356 202,124 -13.43 37.10 -1,163,308 7,498,800
2018-03-28 2018-03-27 4 ATRA Atara Biotherapeutics, Inc.
Common Stock
S - Sale X -22,794 233,480 -8.89 36.43 -830,385 8,505,676
2018-03-28 2018-03-27 4 ATRA Atara Biotherapeutics, Inc.
Common Stock
M - Exercise X 11,406 256,274 4.66 11.00 125,466 2,819,014
2018-03-28 2018-03-27 4 ATRA Atara Biotherapeutics, Inc.
Common Stock
M - Exercise X 32,500 244,868 15.30 22.72 738,400 5,563,401
2018-03-28 2018-03-27 4 ATRA Atara Biotherapeutics, Inc.
Common Stock
M - Exercise X 28,848 212,368 15.72 25.15 725,527 5,341,055
2018-02-20 2018-02-15 4 ATRA Atara Biotherapeutics, Inc.
Restricted Stock Units
M - Exercise -7,211 4,808 -60.00
2018-02-20 2018-02-15 4 ATRA Atara Biotherapeutics, Inc.
Common Stock
F - Taxes -3,604 183,520 -1.93 47.05 -169,568 8,634,616
2018-02-20 2018-02-15 4 ATRA Atara Biotherapeutics, Inc.
Common Stock
M - Exercise 7,211 187,124 4.01
2018-02-12 2018-02-09 4 ATRA Atara Biotherapeutics, Inc.
Common Stock
F - Taxes -3,704 179,913 -2.02 41.70 -154,457 7,502,372
2018-02-08 2018-02-06 4 ATRA Atara Biotherapeutics, Inc.
Employee Stock Option (Right to Buy)
A - Award 50,000 50,000
2018-02-08 2018-02-06 4 ATRA Atara Biotherapeutics, Inc.
Common Stock
F - Taxes -4,437 183,617 -2.36 35.80 -158,845 6,573,489
2018-02-08 2018-02-06 4 ATRA Atara Biotherapeutics, Inc.
Common Stock
A - Award 25,000 188,054 15.33
2017-11-17 2017-11-16 4 ATRA Atara Biotherapeutics, Inc.
Common Stock
S - Sale X -3,290 163,052 -1.98 14.20 -46,718 2,315,338
2017-11-17 2017-11-15 4 ATRA Atara Biotherapeutics, Inc.
Restricted Stock Unites
M - Exercise -7,212 12,019 -37.50
2017-11-17 2017-11-15 4 ATRA Atara Biotherapeutics, Inc.
Common Stock
M - Exercise 7,212 166,342 4.53
2017-08-17 2017-08-16 4 ATRA Atara Biotherapeutics, Inc.
Common Stock
S - Sale X -3,021 159,130 -1.86 14.33 -43,291 2,280,333
2017-08-17 2017-08-15 4 ATRA Atara Biotherapeutics, Inc.
Restricted Stock Unites
M - Exercise -7,211 19,231 -27.27
2017-08-17 2017-08-15 4 ATRA Atara Biotherapeutics, Inc.
Common Stock
M - Exercise 7,211 162,151 4.65
2017-05-17 2017-05-16 4 ATRA Atara Biotherapeutics, Inc.
Common Stock
S - Sale X -3,873 153,000 -2.47 15.25 -59,063 2,333,250
2017-05-17 2017-05-15 4 ATRA Atara Biotherapeutics, Inc.
Restricted Stock Unites
M - Exercise -7,212 26,442 -21.43
2017-05-17 2017-05-15 4 ATRA Atara Biotherapeutics, Inc.
Common Stock
M - Exercise 7,212 156,873 4.82
2017-02-16 2017-02-16 4 ATRA Atara Biotherapeutics, Inc.
Common Stock
S - Sale X -3,059 149,661 -2.00 15.96 -48,822 2,388,590
2017-02-16 2017-02-15 4 ATRA Atara Biotherapeutics, Inc.
Restricted Stock Unites
M - Exercise -7,211 33,654 -17.65
2017-02-16 2017-02-15 4 ATRA Atara Biotherapeutics, Inc.
Common Stock
M - Exercise 7,211 152,720 4.96
2017-02-08 2017-02-06 4 ATRA Atara Biotherapeutics, Inc.
Common Stock
A - Award 49,500 144,687 52.00
2016-11-17 2016-11-16 4 ATRA Atara Biotherapeutics, Inc.
Common Stock
S - Sale X -2,995 95,187 -3.05 19.53 -58,492 1,859,002
2016-11-17 2016-11-15 4 ATRA Atara Biotherapeutics, Inc.
Restricted Stock Unites
M - Exercise -7,212 40,865 -15.00
2016-11-17 2016-11-15 4 ATRA Atara Biotherapeutics, Inc.
Common Stock
M - Exercise 7,212 98,182 7.93
2016-08-17 2016-08-15 4 ATRA Atara Biotherapeutics, Inc.
Restricted Stock Unites
M - Exercise -7,211 48,077 -13.04
2016-08-17 2016-08-15 4 ATRA Atara Biotherapeutics, Inc.
Common Stock
M - Exercise 7,211 90,970 8.61
2016-05-18 2016-05-16 4 ATRA Atara Biotherapeutics, Inc.
Restricted Stock Unites
M - Exercise -7,212 55,288 -11.54
2016-05-18 2016-05-16 4 ATRA Atara Biotherapeutics, Inc.
Common Stock
S - Sale X -4,153 83,759 -4.72 15.15 -62,918 1,268,949
2016-05-18 2016-05-16 4 ATRA Atara Biotherapeutics, Inc.
Common Stock
M - Exercise 7,212 87,912 8.94
2016-02-18 2016-02-16 4 ATRA Atara Biotherapeutics, Inc.
Restricted Stock Unites
M - Exercise -7,211 62,500 -10.34
2016-02-18 2016-02-16 4 ATRA Atara Biotherapeutics, Inc.
Common Stock
S - Sale X -4,153 80,700 -4.89 15.35 -63,749 1,238,745
2016-02-18 2016-02-16 4 ATRA Atara Biotherapeutics, Inc.
Common Stock
M - Exercise 7,211 84,853 9.29
2016-02-11 2016-02-09 4 ATRA Atara Biotherapeutics, Inc.
Common Stock
A - Award 42,857 77,642 123.21
2015-12-21 2015-12-17 4 ATRA Atara Biotherapeutics, Inc.
Employee Stock Option (Right to Buy)
A - Award 65,000 65,000
2015-11-18 2015-11-16 4 ATRA Atara Biotherapeutics, Inc.
Restricted Stock Units
M - Exercise -4,808 69,711 -6.45
2015-11-18 2015-11-16 4 ATRA Atara Biotherapeutics, Inc.
Common Stock
S - Sale X -4,153 34,785 -10.67 31.67 -131,526 1,101,641
2015-11-18 2015-11-16 4 ATRA Atara Biotherapeutics, Inc.
Common Stock
M - Exercise 4,808 38,938 14.09
2015-08-19 2015-08-17 4 ATRA Atara Biotherapeutics, Inc.
Employee Stock Option (Right to Buy)
M - Exercise X -469 14,531 -3.13
2015-08-19 2015-08-17 4 ATRA Atara Biotherapeutics, Inc.
Employee Stock Option (Right to Buy)
M - Exercise X -1,291 40,042 -3.12
2015-08-19 2015-08-17 4 ATRA Atara Biotherapeutics, Inc.
Restricted Stock Units
M - Exercise -9,615 74,519 -11.43
2015-08-19 2015-08-17 4 ATRA Atara Biotherapeutics, Inc.
Common Stock
S - Sale X -7,829 34,130 -18.66 46.19 -361,622 1,576,465
2015-08-19 2015-08-17 4 ATRA Atara Biotherapeutics, Inc.
Common Stock
M - Exercise X 469 41,959 1.13 11.00 5,159 461,549
2015-08-19 2015-08-17 4 ATRA Atara Biotherapeutics, Inc.
Common Stock
M - Exercise X 1,291 41,490 3.21 25.15 32,469 1,043,474
2015-08-19 2015-08-17 4 ATRA Atara Biotherapeutics, Inc.
Common Stock
M - Exercise 9,615 40,199 31.44
2015-05-19 2015-05-15 4 ATRA Atara Biotherapeutics, Inc.
Restricted Stock Units
M - Exercise 31,250 84,134 59.09
2015-05-19 2015-05-15 4 ATRA Atara Biotherapeutics, Inc.
Common Stock
F - Taxes -13,066 30,584 -29.93 37.30 -487,362 1,140,783
2015-05-19 2015-05-15 4 ATRA Atara Biotherapeutics, Inc.
Common Stock
M - Exercise 31,250 43,650 252.02
2015-01-21 2015-01-16 4 ATRA Atara Biotherapeutics, Inc.
Employee Stock Option (Right to Buy)
M - Exercise 41,333 41,333
2015-01-21 2015-01-16 4 ATRA Atara Biotherapeutics, Inc.
Common Stock
A - Award 12,400 12,400
2014-10-23 2014-10-21 4 ATRA Atara Biotherapeutics, Inc.
Restricted Stock Unit
A - Award 115,384 115,384
2014-10-16 2014-10-15 4 ATRA Atara Biotherapeutics, Inc.
Employee Stock Option (Right to Buy)
M - Exercise 15,000 15,000
P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award, or other acquisition of securities from the company (such as an option)
C
Conversion of derivative
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
G
Gift of securities by or to the insider
K
Equity swaps and similar hedging transactions
M
Exercise or conversion of derivative security received from the company (such as an option)
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)